The Relationship between the Clinical Course of SARS-CoV-2 Infections and Expression of Bruton's Tyrosine Kinase
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Bruton's Tyrosine Kinase (BTK) gene expression was lower in severe COVID-19 cases, suggesting a role in disease pathogenesis. However, BTK levels did not predict patient outcomes.
Area Of Science
- Immunology
- Molecular Biology
- Virology
Background
- Bruton's Tyrosine Kinase (BTK) is crucial for inflammatory cytokine production and may influence COVID-19 pathogenesis.
- Understanding BTK's role can offer insights into COVID-19's inflammatory mechanisms.
Purpose Of The Study
- To investigate Bruton's Tyrosine Kinase (BTK) gene expression in hospitalized COVID-19 patients.
- To correlate BTK expression levels with COVID-19 disease severity and patient outcomes.
Main Methods
- Peripheral blood mononuclear cells (PBMCs) were isolated from 33 hospitalized COVID-19 patients.
- BTK gene expression was quantified and compared between mild-to-moderate and severe-to-critical disease groups.
- Associations between BTK expression, demographics, lab results, and clinical outcomes were analyzed.
Main Results
- BTK expression was significantly lower in patients with severe-to-critical COVID-19 and those admitted to the ICU.
- Lower BTK levels correlated with reduced oxygen saturation.
- No significant difference in BTK expression was found between patients who recovered and those who died.
Conclusions
- BTK gene expression in PBMCs is inversely correlated with COVID-19 severity.
- BTK expression levels do not appear to be a predictor of mortality in COVID-19 patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...